Results 41 to 50 of about 192,096 (187)

Antisense oligonucleotide nomenclature.

open access: yes, 2014
MSP, muscle-specific peptide and B - β-alanine [34].Antisense oligonucleotide nomenclature.
Ben Gu (653768)   +3 more
core   +1 more source

Nuclease-Resistant Composite 2‘,5‘-Oligoadenylate−3‘,5‘-Oligonucleotides for the Targeted Destruction of RNA:  2−5A-Iso-antisense

open access: yes, 2016
A new modification of 2−5A-antisense, 2−5A-iso-antisense, has been developed based on a reversal of the direction of the polarity of the antisense domain of a 2−5A-antisense composite nucleic acid. This modification was able to anneal with its target RNA
Wei Xiao (16583)   +6 more
core   +1 more source

Synthesis and Antisense Properties of 2′β-F-Arabinouridine Modified Oligonucleotides with 4′-C-OMe Substituent

open access: yesMolecules, 2018
A novel 2′-F,4′-C-OMe–arabinouridine (araU) was successfully synthesized and introduced into oligonucleotides. The oligonucleotide containing 2′-F,4′-C-OMe–araU exhibited improved nuclease resistance and RNA ...
Xiao-Yang He   +3 more
doaj   +1 more source

Splicing therapeutics in SMN2 and APOB [PDF]

open access: yes, 2009
Splicing therapeutics are defined as the deliberate modification of RNA splicing to achieve therapeutic goals. Various techniques for splicing therapeutics have been described, and most of these involve the use of antisense oligonucleotide-based ...
Krainer, AR   +3 more
core  

BHRF1 antisense oligonucleotide inhibits anti-apoptosis of nasopharyngeal carcinoma cells

open access: yes, 1999
Epstein-Barr virus gene BHRF1 has homology with proto-oncogene bcl-2, which can protect cells from apoptosis, thus, it may play important roles in oncogenesis and affect treatment of EBV-related cancers.
Huang, H, Zhou, J, Pan, X
core   +1 more source

Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells

open access: yesMolecular Therapy: Nucleic Acids, 2018
Glioblastoma stem cells (GSCs) are invasive, treatment-resistant brain cancer cells that express downregulated in renal cell carcinoma (DRR), also called FAM107A, a genetic driver of GSC invasion.
Amy E. Arnold   +7 more
doaj   +1 more source

Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania

open access: yes, 1999
Antisense oligonucleotides have been considered as inhibitors of growth of intracellular parasites such as Leishmania, but only limited inhibition has been observed in itro.
Dasgupta, Dalia   +7 more
core   +1 more source

Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease

open access: yesFrontiers in Pharmacology, 2019
Several molecular technologies aimed at regulating gene expression that have been recently developed as a strategy to combat inflammatory and neoplastic diseases.
Davide Di Fusco   +5 more
doaj   +1 more source

Antisense Oligonucleotide Therapy for Calmodulinopathy

open access: yesCirculation
BACKGROUND: Calmodulinopathies are rare inherited arrhythmia syndromes caused by dominant heterozygous variants in CALM1 , CALM2 , or CALM3 , which each encode the identical CaM (calmodulin) protein. We hypothesized that antisense
Raul H. Bortolin   +29 more
openaire   +2 more sources

Characterization and Evaluation of NGF Antisense Oligonucleotides: Inhibition of NGF Synthesis in Transfected COS Cells

open access: yes, 1997
We present a system for the assessment of the inhibiting capacity of antisense oligonucleotides. The aim of this study was to identify an oligonucleotide that can inhibit chicken nerve growth factor (NGF) synthesis.
Sahlén, Anders,   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy